Protagenic Therapeutics, Inc.\new (PTIX) › Net IncomeProtagenic Therapeutics, Inc.\new (PTIX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$302.5K2015: -$1.02M2016: -$2.28M2017: -$2.26M2018: -$2.56M2019: -$1.75M2020: -$2.55M2021: -$4.52M2022: -$3.56M2023: -$5.00M2024: -$5.53M-$5.53M2014Net Income (USD)2024Fiscal YearNet IncomeChange YoY2024-$5.53M-10.5%2023-$5.00M-40.6%2022-$3.56M+21.4%2021-$4.52M-77.5%2020-$2.55M-45.6%2019-$1.75M+31.5%2018-$2.56M-13.2%2017-$2.26M+0.7%2016-$2.28M-122.4%2015-$1.02M-238.3%2014-$302.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share